Mendelian randomization study of spermine oxidase and cancer risk
João Fadista(Malmö University), Bjarke Feenstra(Statens Serum Institut), Tõnu Esko(Broad Institute), Lili Milani(University of Tartu), Julie Courraud(Statens Serum Institut), Victor Yakimov(Statens Serum Institut), Frank Geller(Statens Serum Institut), Arieh S. Cohen(Statens Serum Institut), Alfonso Buil(University of Geneva), Christian Stevns Hansen(Steno Diabetes Centers), Thomas Werge(Cardiff University), Jonas Bybjerg‐Grauholm(Johns Hopkins University), Urmo Võsa(University Medical Center Groningen), Silva Kasela(Agency for Science, Technology and Research), David M. Hougaard(Statens Serum Institut), Mads Melbye(University of Copenhagen), Line Skotte(Statens Serum Institut), Viktorija Kukuškina(University of Tartu)
Cited by 0
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
|Nature Genetics|2021|2.2k
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
|Nature Genetics|2018|1.7k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k